Mariacarla Ventriglia

Mariacarla Ventriglia

Auto-generated profile, based on publicly available information

Mariacarla Ventriglia

Department of Neuroscience, AFaR-Fatebenefratelli Hospital, Isola Tiberina 39, 00186 Rome, Italy

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2013 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MVMariacarla Ventriglia
Mariacarla Ventriglia
RZRoberta Zanardini
Roberta Zanardini
CBCristina Bonomini
Cristina Bonomini
OZOrazio Zanetti
Orazio Zanetti
DVDaniele Volpe
Daniele Volpe
LCLuisella Bocchio Chiavetto
Luisella Bocchio Chiavetto
Consistent evidence indicates the involvement of the brain-derived neurotrophic factor (BDNF) in neurodegenerative disorders such as Alzheimer's disease (AD) and Parkinson’s disease (PD). In the present study, we compared serum BDNF in 624 subjects: 266 patients affected by AD, 28 by frontotemporal dementia (FTD), 40 by Lewy body dementia (LBD), 91 by vascular dementia (VAD), 30 by PD, and 169 controls. Our results evidenced lower BDNF serum levels in AD, FTD, LBD, and VAD patients (P<0.001) and a higher BDNF concentration in patients affected by PD (P=0.045). Analyses of effects of pharmacological treatments suggested significantly higher BDNF serum levels in patients taking mood stabilizers/antiepileptics (P=0.009) and L-DOPA (P<0.001) and significant reductions in patients taking benzodiazepines (P=0.020). In conclusion, our results support the role of BDNF alterations in neurodegenerative mechanisms common to different forms of neurological disorders and underline the importance of including drug treatment in the analyses to avoid confounding effects.